Corrigendum to: 6-OHDA mediated neurotoxicity in SH-SY5Y cellular model of Parkinson disease suppressed by pretreatment with hesperidin through activating L-type calcium channels

Articles in the same Issue

1. Frontmatter
2. Editorial
3. IcoSema’s leap forward: new data from COMBINE 3 paves the way
4. Reviews
5. Bimagrumab: an investigational human monoclonal antibody against activin type II receptors for treating obesity
6. The challenge of thigh tendon reinjuries: an expert opinion
7. Original Articles
8. Effect of omega-3 fatty acids supplementation on muscle mass, fat mass, and visceral fat of hemodialysis patients; A randomized clinical trial
9. Identification of ocular artifact in EEG signals using VMD and Hurst exponent
10. Choroidal and retinal alteration after long-term use of tadalafil: a prospective non-randomized clinical trial
11. Short Communication
12. Immediate effect of sunlight exposure through blue glass on blood pressure in hypertensive patients: a randomized controlled trial
13. Letter to the Editor
14. The alarming link between the COVID-19 pandemic and stroke: why ignoring this association after relapse of the disease has dangerous consequences
15. Corrigendum
16. Corrigendum to: 6-OHDA mediated neurotoxicity in SH-SY5Y cellular model of Parkinson disease suppressed by pretreatment with hesperidin through activating L-type calcium channels